Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00609609
What this trial is testing

Photopheresis for the Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
M.D. Anderson Cancer Center 81
Testing effectiveness (Phase 2)Study completedNCT04686929
What this trial is testing

Abatacept s.c. for aGVHD Prevention in Haplo-HCT

Who this might be right for
AbataceptAcute-graft-versus-host DiseaseHaplo-identical HCT+1 more
The First Affiliated Hospital of Soochow University 29
Testing effectiveness (Phase 2)UnknownNCT02659657
What this trial is testing

Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation

Who this might be right for
Acute Graft-versus-host Disease
Peking University People's Hospital 70
Not applicableStudy completedNCT00528853
What this trial is testing

Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation

Who this might be right for
Bronchiolitis Obliterans Syndrome
University of Chicago 10
Not applicableStudy completedNCT02511782
What this trial is testing

Transdermal Patch to Monitor Inflammatory Biomarkers of GVHD

Who this might be right for
Graft Versus Host Disease
Children's Hospital Medical Center, Cincinnati 63
Testing effectiveness (Phase 2)Study completedNCT04943757
What this trial is testing

Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

Who this might be right for
Myeloid Leukemia, AcuteChronic Myeloid LeukemiaMyelodysplastic Syndromes+1 more
St. Petersburg State Pavlov Medical University 50
Early research (Phase 1)Study completedNCT02359929
What this trial is testing

BMT Autologous MSCs for GvHD

Who this might be right for
Graft Versus Host DiseaseAcute Graft Versus Host DiseaseChronic Graft Versus Host Disease
Emory University 11
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075225
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib

Who this might be right for
GVHDAcute Stem Cell Transplant Complications
Sichuan University 62
Testing effectiveness (Phase 2)Study completedNCT03491215
What this trial is testing

Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Novartis Pharmaceuticals 45
Large-scale testing (Phase 3)Study completedNCT03959241
What this trial is testing

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Who this might be right for
Acute LeukemiaChronic Myelogenous Leukemia (CML)Myelodysplasia+1 more
Medical College of Wisconsin 431
Large-scale testing (Phase 3)Study completedNCT00002456
What this trial is testing

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06294691
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

Who this might be right for
Acute Graft-versus-host Disease
Anhui Provincial Hospital 198
Not applicableStudy completedNCT01607580
What this trial is testing

Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD)

Who this might be right for
Leukemia
Peking University People's Hospital 145
Not applicableEnded earlyNCT00651716
What this trial is testing

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Ended earlyNCT00409695
What this trial is testing

Thymoglobulin (ATG) Dose Finding Study

Who this might be right for
Graft vs Host Disease
M.D. Anderson Cancer Center 1
Not applicableNot Yet RecruitingNCT07403500
What this trial is testing

Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain.

Who this might be right for
Back Pain Lower Back Chronic
Centre Hospitalier Universitaire de Nīmes 416
Not applicableEnded earlyNCT02151539
What this trial is testing

Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)

Who this might be right for
Graft Versus Host Disease
Vanderbilt-Ingram Cancer Center 19
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00032292
What this trial is testing

Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
Facet Biotech 34
Next Page